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ABSTRACT 
Background Hypospadias is a common congenital malformation of the male external genitalia. Most 
cases have an unknown aetiology, which is probably a mix of monogenic and multifactorial forms, 
implicating both genes and environmental factors. This review summarizes current knowledge about 
the aetiology of hypospadias. 
Methods Pubmed was used to identify studies on hypospadias aetiology published between January 
1995 and February 2011. Reference lists of the selected manuscripts were also searched to identify 
additional studies, including those published before 1995.  
Results The search provided 922 articles and 169 articles were selected for this review. Studies 
screening groups of patients with hypospadias for single gene defects found mutations in WT1, SF1, 
BMP4, BMP7, HOXA4, HOXB6, FGF8, FGFR2, AR, HSD3B2, SRD5A2, ATF3, MAMLD1, MID1 and 
BNC2. However, most investigators are convinced that single mutations do not cause the majority of 
isolated hypospadias cases. Indeed, associations were found with polymorphisms in FGF8, FGFR2, 
AR, HSD17B3, SRD5A2, ESR1, ESR2, ATF3, MAMLD1, DGKK, MID1, CYP1A1, GSTM1 and 
GSTT1. In addition, gene expression studies indentified CTGF, CYR61 and EGF as candidate genes. 
Environmental factors consistently implicated in hypospadias are low birthweight, maternal 
hypertension and preeclampsia, suggesting that placental insufficiency may play an important role in 
hypospadias aetiology. Exogenous endocrine disrupting chemicals have the potential to induce 
hypospadias but it is unclear whether human exposure is high enough to exert this effect. Other 
environmental factors have also been associated with hypospadias but, for most, the results are 
inconsistent.  
Conclusions Although a number of contributors to the aetiology of hypospadias have been identified, 
the majority of risk factors remain unknown.  
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INTRODUCTION 
Hypospadias is a congenital hypoplasia of the penis, with displacement of the urethral opening along 
the ventral surface, often associated with dorsal hooded foreskin and chordee. More than 50% of cases 
have anterior hypospadias, with a small displacement of the meatus in the glandular region (Fredell et 
al.,2002b; van der Zanden et al.,2010b). Other patients have more substantial displacements, with 
middle (penile) or posterior (penoscrotal, scrotal and perineal) openings (Figure I). Hypospadias is 
usually diagnosed during physical examination of the newborn but localization is best established 
during surgery, after chordee release. Compared to healthy children, boys born with hypospadias more 
often have additional congenital anomalies (Latifoğlu et al.,1998; Akre et al.,1999; Aschim et 
al.,2004a; Nassar et al.,2007), an association that appears to be stronger for posterior compared to 
anterior cases (Latifoğlu et al.,1998; Wu et al.,2002; Nassar et al.,2007). Cryptorchidism in particular 
and other urogenital anomalies are frequently found with hypospadias (Weidner et al.,1999; Nassar et 
al.,2007; Schnack et al.,2009; Akin et al.,2011).  
 
Even when patients receive surgery in their first two years of life, they may encounter severe medical, 
social and sexual problems later in life. After long-term follow-up (10 years) of mainly patients with 
anterior hypospadias who underwent 1-stage repair, different rates of complications in up to 50% of 
patients were reported, depending on inclusion of different aspects (Nuininga et al.,2005). Although 
most studies conclude that psychosocial development is not seriously altered, patients do suffer from 
negative genital appraisal, sexual inhibition, and more erection and ejaculation problems (Mieusset 
and Soulié,2005; Schönbucher et al.,2008).  
 
Prevalence 
Figures on the birth prevalence of hypospadias vary considerably across countries, ranging from four 
to 43 cases per 10,000 births (Kurahashi et al.,2004; Nassar et al.,2007). Hypospadias occurs most 
frequently in whites, less frequently in blacks, and rates are lowest among Asians and Hispanics 
(Gallentine et al.,2001; Carmichael et al.,2003; Yang et al.,2004; Porter et al.,2005; Nelson et 
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al.,2005; Meyer et al.,2006; Forrester and Merz,2006; Carmichael et al.,2007; Nassar et al.,2009). 
There is debate about whether or not the prevalence of hypospadias is increasing. Some researchers 
reported increasing prevalences in China (Sun et al.,2009; Jin et al.,2010), Australia (Nassar et 
al.,2007), the USA (Paulozzi et al.,1997; Nelson et al.,2005) and Europe (Lund et al.,2009), whereas 
others did not find an increase in Canada, the USA (Fisch et al.,2001; Carmichael et al.,2003; Porter et 
al.,2005), Europe (Aho et al.,2000; Ahmed et al.,2004; Abdullah et al.,2007) and Japan (Kurahashi et 
al.,2004). However, results of different studies are difficult to compare because some are based on 
hospital discharge registries, including only surgically treated patients or all newborns diagnosed with 
hypospadias, whereas others are based on birth defects surveillance systems, including all registered 
hypospadias cases or excluding cases with glandular hypospadias. In addition, the diagnosis and 
definition of hypospadias may have changed over time.  
 
Embryology of the male external genitalia 
Indifferent stage 
Early development of the external genitalia is similar for males and females. The embryonic cloaca, 
the far end of the hind gut, is separated from the amniotic cavity by the cloacal membrane. Early in the 
fifth week of development, a swelling develops on both sides of this membrane, the cloacal folds, 
which meet in the midline anterior to the cloacal membrane, forming the genital tubercle 
(Schoenwolf,2009) (Figure II). At the same time, the genital ridges, the precursors of the gonads, 
develop. Studies in mice showed that this process requires Wilms tumour 1 (Wt1) activity, which 
activates splicing factor 1 (Sf1) (Wilhelm and Englert,2002), thus preventing degeneration of the 
developing gonads (Luo et al.,1994). During the seventh week of human development, the urorectal 
septum fuses with the cloacal membrane, dividing the cloaca into the primitive urogenital sinus and 
the rectum, and dividing the cloacal membrane into the urogenital and the anal membrane. The 
swellings next to the urogenital membrane are then called the urogenital folds and a new pair of 
swellings, the labioscrotal swellings, appear on either side of these folds. In addition, the urogenital 
membrane breaks down (Schoenwolf,2009).  
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Early patterning 
The genital tubercle (GT) masculinises if exposed to androgens but early patterning is androgen-
independent. Studies on genes and proteins involved in this patterning process have mainly been 
performed in mice and showed that the distal urethral plate epithelium is the signalling centre 
regulating GT outgrowth (Perriton et al.,2002). Fibroblast growth factor protein (Fgf) and wingless-
type MMTV integration site family member 5A (Wnt5a) signalling have a growth-promoting role in 
this outgrowth (Yamaguchi et al.,1999), whereas bone morphogenetic proteins (Bmps) stimulate 
apoptosis (Morgan et al.,2003; Suzuki et al.,2003). Expression of Fgf8 in the urethral plate is 
regulated by sonic hedgehog (Shh) and homeobox A13 (Hoxa13) (Haraguchi et al.,2001; Perriton et 
al.,2002; Morgan et al.,2003), while Hoxa13 also regulates expression of Bmp7 (Morgan et al.,2003). 
Shh induces, either directly or via Fgf8 or other factors, expression of Fgf10, Bmp2, Bmp4, Wnt5a, 
Patched 1 (Ptch1), Msh homeobox 1 (Msx1) and Hoxd13 (Haraguchi et al.,2001; Perriton et al.,2002). 
Shh thus modulates the balance between proliferation and apoptosis (Haraguchi et al.,2001) and 
regulates the initiation of GT outgrowth (Perriton et al.,2002). Immunohistochemical staining of 
human foetal penises showed expression of SHH, its receptor PTCH1, and its downstream genes 
smoothened, frizzled family receptor (SMO) and GLI family zinc finger 1 (GLI1) around the time of 
urethral closure (Shehata et al.,2011). Studies in mice showed that Wnt-β-catenin signalling also 
seems to play a role in GT development, either in early androgen-independent GT development (Lin et 
al.,2008) or as a downstream effector of androgen signalling essential for GT masculinisation 
(Miyagawa et al.,2009).  
 
Masculinisation 
Subsequent masculinisation relies on hormones produced by the testes. Expression of the sex-
determining region Y gene (SRY) induces a cascade of gene interactions, involving SRY-box 9 (SOX9) 
(Schoenwolf,2009), resulting in differentiation of the gonads into the testes (Sinclair et al.,1990). SRY 
leads to the differentiation of Sertoli cells (Schoenwolf,2009), which secrete anti-Müllerian hormone 
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(AMH). Studies in mice showed that AMH secretion happens under the influence of Sf1 (Giuili et 
al.,1997). AMH causes regression of the Müllerian ducts that would otherwise form part of the female 
genital structures (Schoenwolf,2009). HCG, produced by the placenta, controls foetal Leydig cell 
growth and stimulates foetal testicular steroidogenesis, the generation of steroids from cholesterol 
(Misrahi et al.,1998). The enzymatic steps of steroidogenesis, mainly taking place in the Leydig cell, 
are well documented and expression of key genes in this pathway is dependent on expression of SF1 
(Scott et al.,2009) (Figure III). Testosterone leaves the Leydig cell and is converted into 
dihydrotestosterone (DHT) by steroid-5-alpha-reductase (SRD5A). Testosterone promotes formation 
of the internal reproductive structures from the Wolffian ducts, whereas DHT induces development of 
the external genitalia (Schoenwolf,2009), both through their effect on the androgen receptor (AR). 
Expression of estrogen receptors (ESR) in male genital tissue during development suggests that the 
balance between androgens and estrogens is important as well (Crescioli et al.,2003). 
 
During masculinisation of the external genitalia, between the 12th and 14th week after conception 
(Schoenwolf,2009), the GT develops into the penis, the labioscrotal swellings fuse to form the scrotum 
(Ammini et al.,1997; Schoenwolf,2009) and the urogenital folds close in a proximal to distal direction 
to form the penile urethra (Ammini et al.,1997; van der Werff et al.,2000; Schoenwolf,2009; Yamada 
et al.,2003; Hynes and Fraher,2004b) (Figure II). Several hypotheses have been proposed about 
formation of the glandular portion of the urethra. One of these states that, while the penile urethra is 
created by fusion and primary luminisation, the glandular urethra develops by fusion and secondary 
luminisation (van der Werff et al.,2000). According to another hypothesis, the complete urethra arises 
by fusion of the urogenital folds (Ammini et al.,1997; Baskin et al.,2001). Still others believe that the 
glandular portion of the urethra originates from a different set of folds (Hynes and Fraher,2004a), 
ingrowth of surface cells (Jones,1910) or canalization of the urethral plate (Schoenwolf,2009).  
 
As a result, the development of hypospadias is also controversial. From a clinical point of view, 
development of the urethra, corpora, glans and penile skin are directly correlated. In posterior 
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hypospadias, there is non-fusion of the labioscotal swellings with a distal dysplasia of the urethral 
plate and corpora, as well as non-fusion of the glans and skin in the midline. In middle hypospadias, 
the distal part of the penis shows a persistence of the urethral plate and non-tubularisation of the glans 
with disturbed penile skin formation. In glandular hypospadias, there is a dimple or a short tubular 
tract with a septum in between this tract and the urethral plate or tube and no closure of the skin in the 
midline. In the most minimal form, hypospadias sine hypospadias, only non-fusion of the preputial 
skin on the ventral side is seen, with dorsal hooded foreskin with or without some chordee.  
 
Aim of this review 
In 30% of the least frequently occurring posterior hypospadias cases a cause can be identified, for 
example, a complex genetic syndrome, partial androgen insensitivity related to AR mutations, or 
SRD5A type II deficiency (Albers et al.,1997; Boehmer et al.,2001). The aetiology of most other 
hypospadias cases, however, is not yet solved in spite of intensive research. In this review, we will 
summarize the current knowledge about the causes of the isolated, non-syndromic form of this 
common birth defect in humans, from both a genetic and an environmental point of view. In addition, 
we will provide recommendations for further research. 
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METHODS 
Pubmed was used to identify all relevant manuscripts on the aetiology of hypospadias. We searched 
for papers published between January 1995 and February 2011 in the English language using the 
following keywords in the title or abstract: “(hypospadia OR hypospadias) NOT surgical NOT surgery 
NOT reconstruction NOT repair NOT incised NOT procedure”. This search provided 922 articles, of 
which we used the titles and abstracts to identify relevant papers. We focussed our review on the 
aetiology of isolated hypospadias in humans. Therefore, we excluded all animal studies (N = 99), 
articles that were not about hypospadias or the aetiology of hypospadias (N = 235), and articles or 
case-reports that described the phenotype of patients suffering from syndromes including hypospadias, 
or that investigated or described the most likely cause of the syndrome in these boys (N = 308). To 
systematically exclude articles with a lesser degree of evidence, we excluded all ecological studies (N 
= 11). For epidemiologic studies reporting negative findings for environmental factors, we took the 
power into consideration before reporting that it showed no association. In general, we excluded 
negative results on environmental factors from studies describing <100 cases, as these have, for 
example, only 37% power to significantly (P<0.05) detect a two-fold increased risk, assuming a 
prevalence of 10% (15 studies were completely excluded because of this criterion). To guarantee that 
all information was included only once in the article, we excluded all reviews and meta-analyses (N = 
79). In addition, when a study was supplemented with new data in a later publication (N= 3), we only 
included the article reporting the most complete data. Finally, all commentaries were excluded (N = 
32). Reference lists of the selected manuscripts were searched to identify additional studies, including 
those published before 1995, although these were only included if they reported results that were not 
found in one of the more recently published articles (N = 29). This selection process resulted in 169 
original articles that were included in this review and are described below. 
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RESULTS 
Aetiology of hypospadias is multifactorial 
Hypospadias shows familial clustering, with 7% of cases having affected first, second or third degree 
relatives (Fredell et al.,2002b). Familial occurrence seems to be more common for anterior and middle 
forms of hypospadias than for posterior types (Fredell et al.,2002b; Brouwers et al.,2010). The chance 
that a brother of an affected boy will also have hypospadias is 9 to 17% (Calzolari et al.,1986; Stoll et 
al.,1990; Schnack et al.,2008). In two family studies and one small twin study, the heritability of 
hypospadias was estimated to be 57 to 77% (Calzolari et al.,1986; Stoll et al.,1990; Schnack et 
al.,2008), meaning that 57 to 77% of the phenotypic variability can be attributed to genetic variability. 
Because hypospadias is equally transmitted through the maternal and paternal sides of the family and 
recurrence risks for brothers and sons of hypospadias cases are similar, genetic rather than shared 
environmental factors may play a principal role in familial hypospadias (Schnack et al.,2008). 
Segregation analysis, however, suggested that the majority of cases have a multifactorial aetiology, 
involving both genes and environmental factors (Fredell et al.,2002a).  
 
Genes implicated in the aetiology of isolated hypospadias 
Much of the genetic research on hypospadias has been focused on identification of causal mutations. 
In Table I, we summarize the exonic (including 3’-untranslated and splice acceptor site) mutations 
found in studies screening candidate genes in groups of patients with hypospadias, ordered according 
to the different stages of embryonic development. Whether these mutations have functional 
consequences remains unclear in most cases, as only few studies reported conservation and function of 
the region in which the mutation is located, or predicted potential influence of the mutation on protein 
function using bioinformatics. The majority of mutations were found only once and were identified in 
posterior or penile cases. The latter has contributed to the view that there is a difference in the genetic 
models underlying posterior versus anterior hypospadias, with posterior cases being more common in 
monogenic forms of hypospadias and anterior cases having a polygenic or multifactorial aetiology. 
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The studies investigating associations between genetic polymorphisms and hypospadias are 
summarized in Table II (following the same order as Table I). 
 
Indifferent stage 
All genes involved in the development of the male external genitalia are obvious candidate genes for 
hypospadias. Because Wt1 and Sf1 play major roles in early embryonic development of the kidneys 
and the urogenital system, mutations in these genes are likely to cause not only hypospadias but also 
more severe defects. Indeed, SF1 mutations were found in severe penoscrotal hypospadias cases with 
cryptorchidism (Köhler et al.,2009), while a mutation in WT1 was described in a boy with penoscrotal 
hypospadias and micropenis and also in three boys with isolated penile or glandular hypospadias 
(Wang et al.,2004) (Table I). 
 
Early patterning 
Genes involved in GT patterning are additional candidates for hypospadias. Mutation screening in 
hypospadias cases revealed mutations in BMP4, BMP7, HOXA4, HOXB6, FGF8, and the fibroblast 
growth factor receptor FGFR2 (Chen et al.,2007; Beleza-Meireles et al.,2007c) (Table I), while 
associations with hypospadias were also observed for polymophisms in FGF8 and FGFR2 (Beleza-
Meireles et al.,2007c) (Table II).  
 
Masculinisation 
Expression of the SRY gene, located on the Y chromosome, is crucial for development of the testis 
from the indifferent gonad (Sinclair et al.,1990; Gubbay et al.,1990). Sex chromosome abnormalities 
were noticed in four out of 100 patients with hypospadias (Moreno-García and Miranda,2002) but no 
mutations in SRY were found in 90 patients in another study (Wang et al.,2004). In addition, screening 
Yq for microdeletions in 44 cases did not reveal any abnormalities (Tateno et al.,2000) and neither did 
screening the segments of the Y chromosome associated with infertility in 20 cases with middle or 
posterior hypospadias and cryptorchidism (Castro et al.,2004). 
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Genetic research has been focused on the hormone-dependent stage of sexual development as well. 
The gene encoding AR in particular was investigated extensively. AR is expressed in the developing 
human penis and urethra (Kim et al.,2002) and several studies reported rare mutations in the gene 
encoding AR in patients with hypospadias (Hiort et al.,1994; Alléra et al.,1995; Sutherland et 
al.,1996; Nordenskjöld et al.,1999; Wang et al.,2004; Thai et al.,2005) (Table I). In addition, 
polymorphisms in AR have been investigated for associations with the anomaly and may increase 
hypospadias risk. For example, expansion of the polyglutamine (CAG) repeat in the N-terminus of AR, 
shown to decrease AR transactivation function (Chamberlain et al.,1994), was found to be associated 
with undermasculinisation (Lim et al.,2000). Two studies reported that longer GGN repeat length 
increased the risk of penile hypospadias (Aschim et al.,2004b; Radpour et al.,2007) but these two (and 
one other) studies did not find an association between CAG repeat length and hypospadias (Muroya et 
al.,2001; Aschim et al.,2004b; Radpour et al.,2007) (Table II). DHT binding capacity of the AR in 
genital skin fibroblasts was reported to be decreased in some patients with hypospadias (Schweikert et 
al.,1989; Alléra et al.,1995), whereas normal binding capacity was found in others (Gearhart et 
al.,1988; Terakawa et al.,1990). In addition, AR levels were similar in foreskin samples of 
hypospadias cases and controls (Bentvelsen et al.,1995). 
 
Several proteins are needed for AR function. FK506 binding protein 4, 59kDa (FKBP4, also known as 
FKBP52), for example, is a component of AR complexes, enhancing AR-mediated transactivation 
(Cheung-Flynn et al.,2005). However, no differences in FKBP4 expression were noted between 
patients with hypospadias and controls and no mutations in FKBP4 were observed (Beleza-Meireles et 
al.,2007a). 
 
As normal male urethral development requires testosterone and DHT, defects in steroidogenesis could 
also account for hypospadias. One article stated that up to 50% of patients with hypospadias have a 
testosterone biosynthesis defect (Aaronson et al.,1997), a conclusion that could not be confirmed in 
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two other studies that found no enzymatic defects (Feyaerts et al.,2002; Holmes et al.,2004). 
Nevertheless, mutations have been found in hydroxy-delta-5-steroid dehydrogenase, 3 beta- and 
steroid delta-isomerase 2 (HSD3B2) (Codner et al.,2004) and SRD5A type II (SRD5A2) (Silver and 
Russell,1999; Wang et al.,2004; Thai et al.,2005).  
 
The gene encoding SRD5A2 is particularly interesting because this enzyme is expressed during male 
genital development around the ventral part of the remodelling urethra and it converts testosterone to 
the more potent androgen DHT, which induces formation of the external genitalia (Kim et al.,2002). 
Two single nucleotide polymorphisms (SNPs) in this gene seemed to be associated with hypospadias 
in some but not all studies (Silver and Russell,1999; Wang et al.,2004; Thai et al.,2005; Sata et 
al.,2010; van der Zanden et al.,2010b) (Table II). One of these SNPs (rs523349) causes a valine to 
leucine substitution (V89L), resulting in a decrease in enzyme activity by approximately 30% 
(Makridakis et al.,1997; Makridakis et al.,2000), whereas the other SNP (rs9282858) results in an 
alanine to threonine replacement (A49T), which causes an increase in enzyme function (Makridakis et 
al.,2000). Another SNP that seems to be associated with hypospadias and to have functional 
consequences is rs2066479 in HSD17B3. The glycine to serine substitution (G289S) caused by this 
SNP results in reduced HSD17B3 mRNA expression levels in utero (Sata et al.,2010). 
 
Other genes 
Not only steroidogenesis but also the balance between androgens and estrogens appears to be 
important in development of the male external genitalia. The estrogen receptors ESR1 and ESR2 are 
expressed in the developing human male GT (Crescioli et al.,2003) and associations have been 
reported between hypospadias and several SNPs in the genes encoding these receptors, as well as with 
the CA-repeat in ESR2 (Beleza-Meireles et al.,2006; Watanabe et al.,2007; Beleza-Meireles et 
al.,2007b; Ban et al.,2008; van der Zanden et al.,2010b) (Table II). One of the SNPs in ESR1, 
rs9340799, was shown to increase enhancer activity of ESR1 (Maruyama et al.,2000).  
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Some additional genes are also suggested to be involved in development of hypospadias. Activating 
transcription factor 3 (ATF3) is an estrogen-responsive gene showing strong up-regulation in 
hypospadias (Liu et al.,2005; Wang et al.,2007; Kalfa et al.,2008a; Gurbuz et al.,2010). Studies 
focusing on the relation between this gene and hypospadias found mutations and associations with 
several SNPs (Beleza-Meireles et al.,2008; Kalfa et al.,2008a) but not all associations could be 
replicated (van der Zanden et al.,2010b) (Tables I and II). Recently, mastermind-like domain 
containing 1 (MAMLD1, previously known as CXorf6) was identified as a causal gene for 
hypospadias. MAMLD1 contains the SF1 target sequence (Fukami et al.,2008) and mutations and 
polymorphisms in MAMLD1 have been found in patients with hypospadias (Fukami et al.,2006; Kalfa 
et al.,2008b; Chen et al.,2010) (Tables I and II). A recent genome-wide association study using pooled 
DNA samples identified diacylglycerol kinase, kappa (DGKK) as a major risk gene for hypospadias 
(van der Zanden et al.,2010a). An intronic SNP was associated with a 2.5 times increased hypospadias 
risk, while DGKK expression in preputial skin was shown to be lower in boys carrying the risk allele. 
In the van der Zanden et al. (2010a) study, additional candidate genes i.e. peroxisome proliferator-
activated receptor gamma, coactivator 1 beta (PPARGC1B), glutamate receptor, ionotropic, delta 1 
(GRID1) and KIAA2022 were also identified but these still need to be confirmed. One study 
investigated MID1 in relation to hypospadias and found mutations in patients with hypospadias as well 
as a SNP in this gene to be associated with the disorder (Zhang et al.,2011) (Tables I and II). Insulin-
like 3 (INSL3) mutations have been found in patients with cryptorchidism but no alterations were 
detected in 94 hypospadias cases (El Houate et al.,2007) (Table I). 
 
Expression studies have also identified some candidate genes. Using prepuce samples of patients with 
hypospadias and controls, Wang et al. (2007) not only found ATF3 to be upregulated in patients but 
also connective tissue growth factor (CTGF) and cysteine-rich, angiogenic inducer, 61 (CYR61), two 
other estrogen-responsive genes. In addition, epidermal growth factor (EGF) staining in prepuce 
showed lower expression of EGF within the penile skin adjacent to the urethra in patients with 
hypospadias compared to controls (el-Galley et al.,1997).  
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A balanced translocation in a man with hypospadias and other congenital anomalies indicated 
basonuclin 2 (BNC2) as a candidate gene. This gene is expressed in developing human periurethral 
tissue and mutations were found in 6 out of 48 patients with hypospadias but also in 2 out of 23 
controls (Bhoj et al.,2011) (Table I). 
 
As exposure to environmental toxicants has also been suggested to cause hypospadias, and 
cytochrome P4501A1 (CYP1A1) and glutathione S-transferases (GSTM1 and GSTT1) are involved in 
the metabolism of various toxicants, two studies evaluated the effect on hypospadias risk of 
polymorphisms in the genes encoding these enzymes. One study found an association with 
hypospadias for concomitant deletion of GSTM1 and GSTT1 (Yadav et al.,2011) (Table II). The other 
study investigated associations between maternal smoking, maternal SNPs in the genes and the risk of 
hypospadias in offspring. They found an association between a SNP in CYP1A1 and hypospadias, 
which was not modified by smoking behaviour (Kurahashi et al.,2005). 
 
One genome-wide linkage analysis in 69 families with at least 2 members with hypospadias found 
suggestive linkage at 9q22, 2p11, 10p15 and 10q21 (Frisen et al.,2004), while another linkage study in 
a three-generational family showing autosomal dominant inheritance of hypospadias found a peak on 
7q32.2-q36.1 (Thai et al.,2008). Mutation analysis of two genes in this region, AKRID1 and PTN, 
failed to reveal any mutations (Thai et al.,2008). 
 
Screening 17 isolated patients with hypospadias and 12 patients with associated anomalies for copy 
number variants (CNVs) revealed clinically significant CNVs in 3 patients with isolated hypospadias 
(5p15, 12p13 and Xq28) and in 2 patients with an associated anomaly, which were cryptorchidism 
(2q22) and cleft palate (16p11) (Tannour-Louet et al.,2010).     
 
The role of environmental factors in the aetiology of hypospadias 
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Introduction 
 
While genes involved in the aetiology of hypospadias have received a considerable amount of 
attention, research on environmental factors has been even more extensive. Despite the large number 
of studies, however, clear evidence for causal environmental factors is still lacking, although some 
consistent associations have been reported. Table III gives a summary of environmental factors 
investigated in relation to hypospadias. 
 
Testicular dysgenesis syndrome 
In 2001, Skakkebæk et al. suggested that poor sperm quality, testicular cancer, undescended testes and 
hypospadias are symptoms of one underlying entity, the Testicular Dysgenesis Syndrome (TDS) 
(Skakkebæk et al.,2001). They were convinced of its existence because countries with high incidences 
of testicular cancer also had high prevalence rates of hypospadias, cryptorchidism and poor sperm 
quality (Virtanen et al.,2005). Other researchers question whether TDS actually exists as there is little 
evidence of shared causes (Akre and Richiardi,2009), only a few patients display all features, and 
incidences of the four components of the syndrome did not increase over time at the same rate (Thorup 
et al.,2010). Although testicular germ cell cancer risk was increased in patients with hypospadias or 
undescended testis, risk was not increased in their family members. This does not support the 
hypothesis of shared heritability (Schnack et al.,2010). Recently, Skakkebæk et al. concluded that 
TDS does exist but that it encompasses only a fraction of hypospadias and impaired spermatogenesis 
cases (Jørgensen et al.,2010).  
 
Estrogen hypothesis  
In 1993, Sharpe and Skakkebæk hypothesized that the increasing incidence of reproductive 
abnormalities in males may have a common cause, namely increased estrogen exposure in utero, 
leading to disturbances in AMH secretion or impairment of Leydig cell development (Sharpe and 
Skakkebæk,1993). Ten years after the introduction of this hypothesis, Sharpe concluded that evidence 
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for foetal estrogen exposure inducing TDS had strengthened (Sharpe,2003). New pathways were 
identified through which estrogens could induce TDS, including suppression of testosterone 
production, AR expression and insulin-like 3 secretion. Whether increased estrogen exposure will turn 
out to be an important aetiologic factor for TDS is not so certain, however.  
 
The initial ‘estrogen hypothesis’ was superseded by a more refined definition of endocrine disrupting 
chemicals (EDCs), suggesting that chemicals may act on the endocrine systems in a plethora of ways 
(Fisher,2004). In 2008, Sharpe and Skakkebæk highlighted the central role of deficient androgen 
production or action during foetal testis development in the origin of the downstream disorders of TDS 
(Sharpe and Skakkebæk,2008). However, the question remains whether levels of exposure to EDCs 
are sufficient to influence male reproductive health (Fisher,2004) and several reviews concluded that 
there is little evidence for a role of environmental EDCs (Raman-Wilms et al.,1995; Safe,2000; 
Chia,2000; Vidaeff and Sever,2005; Storgaard et al.,2006; Martin et al.,2008).  
 
Exogenous exposure to estrogens 
Oral contraceptives 
Although oral contraceptives probably provide the strongest estrogen exposure that humans can 
experience, an association between hypospadias and use of oral contraceptives for some time during 
pregnancy was not found in most studies (Morera et al.,2006; Wogelius et al.,2006; Brouwers et 
al.,2007; Akre et al.,2008; Nørgaard et al.,2009; Brouwers et al.,2010).  
 
Assisted reproductive technology 
Assisted reproductive technologies (ART) frequently involve hormonal stimulation and some studies 
showed an increased risk of hypospadias with ART (Carmichael et al.,2007; Brouwers et al.,2007; 
Brouwers et al.,2010). More specifically, ICSI increased hypospadias risk in most (Wennerholm et 
al.,2000; Ericson and Källén,2001; Pinborg et al.,2004; Källén et al.,2005; Fedder et al.,2007; Funke 
et al.,2010) but not all studies (Bonduelle et al.,2002; Källén et al.,2010), whereas studies on IVF did 
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not report increased risks or were inconclusive (Ericson and Källén,2001; Bonduelle et al.,2002; 
Morera et al.,2006; Funke et al.,2010; Källén et al.,2010), except for one study that did not report 
whether ICSI was excluded (Silver et al.,1999). In one study, increased hypospadias risk was 
associated with hormonal stimulation (Carmichael et al.,2005a) but this was not confirmed in other 
studies (Källén et al.,2002; Sørensen et al.,2005b; Morera et al.,2006; Meijer et al.,2006).  
 
Other authors assumed that the increased hypospadias risk may be explained by reduced maternal or 
paternal fertility. Fathers of hypospadias cases were reported to have lower sperm concentration, 
sperm count (Asklund et al.,2007) and sperm motility, as well as a higher proportion of abnormal 
sperm morphology (Fritz and Czeizel,1996). In addition, several studies reported a prolonged time-to-
pregnancy (TTP) for parents of patients with hypospadias (Källén,2002; Pierik et al.,2004; Asklund et 
al.,2007; Brouwers et al.,2010) and only one study did not confirm these results (Akre et al.,1999). 
The fact that ICSI, rather that IVF, and sperm quality are associated with hypospadias supports the 
idea that paternal fertility problems in particular play a role in hypospadias (Brouwers et al.,2007; 
Brouwers et al.,2010). 
 
ART may be associated with genomic imprinting disorders (Laprise,2009). This possible interference 
with epigenetic regulation is another mechanism by which ART could increase hypospadias risk. A 
very recent study indicated that alterations in the methylation pattern of AR, leading to abnormal 
expression of the gene in foreskin tissue from patients, may contribute to the development of 
hypospadias (Vottero et al.,2011).    
 
Endogenous hormone levels 
Endogenous estradiol levels 
Endogenous levels of free estradiol increase with increasing BMI and are elevated in women with an 
early age at menarche (Apter and Vihko,1983; Emaus et al.,2008). Several studies found associations 
between hypospadias and mothers being overweight (25≤BMI<30 kg/m2) (Waller et al.,2007) or 
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severely overweight or obese (BMI>29 or 30 kg/m2) (Waller et al.,2007; Akre et al.,2008; Giordano et 
al.,2010; Blomberg and Källén,2010) but one study did not (Brouwers et al.,2010). Another study 
found increased risks for underweight but not for overweight or obese women (Rankin et al.,2010). 
The results for early age at menarche were inconsistent (Morera et al.,2006; Giordano et al.,2010). 
Estradiol levels are also higher in first pregnancies and twin pregnancies (Kappel et al.,1985; 
Bernstein et al.,1986), which were both repeatedly investigated for their association with hypospadias. 
Most studies showed that women in their first pregnancy (Akre et al.,1999; Weidner et al.,1999; 
Hussain et al.,2002; Källén,2002; Carmichael et al.,2003; Aschim et al.,2004a; Sørensen et al.,2005a; 
Meyer et al.,2006; Morera et al.,2006; Carmichael et al.,2007; Nassar et al.,2009; Jin et al.,2010) or 
with a twin or triplet pregnancy (Akre et al.,1999; Fredell et al.,2002b; Morera et al.,2006; Brouwers 
et al.,2007; Carmichael et al.,2007; Sun et al.,2009; Nassar et al.,2009; Brouwers et al.,2010; Funke et 
al.,2010; Jin et al.,2010) were at increased risk of having a son with hypospadias but a few studies 
could not replicate the findings for primiparity or for multiple pregnancies (Weidner et al.,1999; 
Carmichael et al.,2003; Aschim et al.,2004a; Sørensen et al.,2005a; Ghirri et al.,2009). The latter may 
be caused by overadjustment for birthweight in some studies. As only early-onset intrauterine growth 
restriction (IUGR) could be a risk factor for hypospadias, it is more likely that low birthweight and 
hypospadias share an underlying cause rather than low birthweight being a risk factor for hypospadias.  
 
Foetal hCG provision 
Placental hCG stimulates foetal testicular steroidogenesis before the foetus’s own pituitary-gonadal 
axis is established. Placental insufficiency may result in inadequate foetal hCG provision and IUGR, 
possibly explaining the association between hypospadias and low birthweight or being small for 
gestational age (SGA) that was consistently reported, although not always statistically significant 
(Weidner et al.,1999; Akre et al.,1999; Gatti et al.,2001; Hughes et al.,2002; Hussain et al.,2002; 
Fredell et al.,2002b; Carmichael et al.,2003; Pierik et al.,2004; Aschim et al.,2004a; Boisen et 
al.,2005; Chong et al.,2006; Morera et al.,2006; Brouwers et al.,2007; Akre et al.,2008; Giordano et 
al.,2008; Sun et al.,2009; Nassar et al.,2009; Ghirri et al.,2009; Brouwers et al.,2010; Funke et 
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al.,2010; Jin et al.,2010; Giordano et al.,2010). However, because hCG levels were similar in maternal 
serum samples of hypospadias cases and controls, this is unlikely to be related to decreased maternal 
hCG production (Kiely et al.,1995). IUGR was also found more often in the affected twin of same-sex 
twin pairs discordant for hypospadias (Fredell et al.,1998; Chambers et al.,2006). Direct proof of a 
link between placental insufficiency and hypospadias was provided by research showing an 
association between hypospadias and low placental weight (Stoll et al.,1990), an increased frequency 
of placental infarction among extremely low birthweight boys with hypospadias (Fujimoto et al.,2008) 
and a high rate of early-onset IUGR related to placental insufficiency among SGA newborns with 
hypospadias, with the more posterior cases having more severe IUGR (Yinon et al.,2010). The 
association with low birthweight also seems to be stronger for more posterior forms of hypospadias 
(Carmichael et al.,2003; Carlson et al.,2009; Ghirri et al.,2009; Brouwers et al.,2010).  
Nausea in early pregnancy may be caused by the early surge of hCG (Furneaux et al.,2001), 
suggesting that placental insufficiency may cause absence of nausea. Indeed, vomiting and nausea 
during early pregnancy were shown to decrease hypospadias risk (Carmichael et al.,2007; Akre et 
al.,2008). Maternal hypertension during pregnancy (Morera et al.,2006; Akre et al.,2008; Caton et 
al.,2008; Sun et al.,2009; Brouwers et al.,2010) and preeclampsia (Akre et al.,1999; Aschim et 
al.,2004a; Sørensen et al.,2005a; Chong et al.,2006; Morera et al.,2006; Sun et al.,2009; Brouwers et 
al.,2010) were consistently associated with hypospadias, and both factors may be associated with 
placental dysfunction, possibly by compromising uteroplacental perfusion (Caton et al.,2008). Preterm 
delivery may be associated with late placental dysfunction and several studies demonstrated an 
association with hypospadias (Pierik et al.,2004; Meyer et al.,2006; Akre et al.,2008; Sun et al.,2009; 
Nassar et al.,2009; Funke et al.,2010; Jin et al.,2010; Giordano et al.,2010; Akin et al.,2011) while 
others could not confirm this (Akre et al.,1999; Weidner et al.,1999; Carmichael et al.,2003; Aschim 
et al.,2004a; Chong et al.,2006; Ghirri et al.,2009), again possibly because of overadjustment for 
birthweight in some studies. 
 
Clinical factors 
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Pregnancy complications 
In a few studies, associations were investigated between hypospadias and complications during 
pregnancy, such as maternal bleeding, which seemed to be more prevalent among cases (Aschim et 
al.,2004a; Jin et al.,2010). The amount of weight gain was not associated with hypospadias (Morera et 
al.,2006; Meyer et al.,2006). Complications during labour, such as labour induction and Caesarean 
section, occurred more frequently among mothers of hypospadias cases (Aschim et al.,2004a; Meyer 
et al.,2006), indicating that  pregnancies affected by hypospadias are associated with other difficulties 
that make them prone to these complications. Diabetes has been another focus of research, but most 
studies were too small to draw conclusions (Hussain et al.,2002; Sørensen et al.,2005a; Morera et 
al.,2006; Sun et al.,2009; Brouwers et al.,2010). One study found maternal gestational and pre-
existing diabetes not to be associated with occurrence of hypospadias (Aschim et al.,2004a), whereas 
others reported an increased risk for pre-existing but not for gestational diabetes (Åberg et al.,2001; 
Porter et al.,2005). Results were inconsistent for thyroid disease (Aschim et al.,2004a; Browne et 
al.,2009) and fever during pregnancy (Stoll et al.,1990; Jin et al.,2010). Women with gynaecological 
diseases (ovarian cysts or benign uterine tumours) (Giordano et al.,2008), those who are carriers of 
hepatitis B antigen (Sun et al.,2009) and women experiencing a viral infection or influenza in the first 
trimester of pregnancy (North and Golding,2000; Morera et al.,2006) seem to be at increased risk of 
giving birth to a son with hypospadias but evidence was derived from only one study. Urinary 
infections and anaemia do not seem to increase hypospadias risk (Aschim et al.,2004a).  
 
Maternal drug use 
Most therapeutic drugs, such as corticosteroids, antibiotics, antipsychotics, antifungal and anti-
asthmatic drugs, do not seem to be associated with hypospadias, although some studies may suffer 
from under reporting (Czeizel and Rockenbauer,1997; Czeizel et al.,2001; Brouwers et al.,2007; 
Källén and Otterblad,2007; Carter et al.,2008; Carmichael et al.,2009a; Brouwers et al.,2010). Based 
on data from the Swedish Medical Birth Register 1995-2001, Källén et al. reported 15 hypospadias 
cases in 2780 infants born after maternal use of loratadine, an antihistamine, during pregnancy (Källén 
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and Olausson,2001) but in 2001-2004 only two cases were identified among 1911 infants exposed to 
loratadine, indicating that the primary finding occurred by chance (Källén and Olausson,2006). Other 
studies also failed to find an association between loratadine and hypospadias (CDC 2004; Pedersen et 
al.,2008). Results for progestogens/progestins used for threatened abortion vary (Katz et al.,1985; 
Calzolari et al.,1986). Use of loperamide (Källén et al.,2008), antiretroviral therapy (Watts et 
al.,2007), antihypertensive drugs (Caton et al.,2008; Brouwers et al.,2010), nystatin (Czeizel et 
al.,2003) or paroxetine (Reis and Källén,2010) during early pregnancy may increase hypospadias risk, 
while codeine (North and Golding,2000) may decrease the risk but most of these associations were 
reported only once. In contrast, use of anti-epileptic drugs was linked to hypospadias several times 
(Arpino et al.,2000; Hunt et al.,2008; Rodríguez-Pinilla et al.,2008; Bánhidy et al.,2010; Jentink et 
al.,2010). Most studies showed no effects of folate (Källén,2007; Carmichael et al.,2009b; Brouwers 
et al.,2010) or iron supplementation (Morera et al.,2006; Brouwers et al.,2010) on hypospadias risk, 
although one study showed a reduced risk of folate (Ormond et al.,2009) and two others an increased 
risk of iron supplementation (North and Golding,2000; Brouwers et al.,2007).  
 
Maternal intrauterine DES exposure 
In 2002, Klip et al. reported a 21 times increased hypospadias risk among sons of women exposed to 
diethylstilbestrol (DES) in utero in a cohort of women with fertility problems (Klip et al.,2002). 
Thereafter, other studies were consistent in showing an increased risk for sons of DES-daughters, 
although less strong (Palmer et al.,2005; Pons et al.,2005; Brouwers et al.,2006; Brouwers et 
al.,2010). This transgenerational effect may have been related to genetic or epigenetic changes in 
primordial oocytes, which were transmitted to the next generation, or in somatic cells of the DES-
daughter, resulting in disturbed hormonal balance in adult life (Klip et al.,2002). Another explanation 
would be that pathology of the DES-daughter’s reproductive structures interferes with normal foetal 
development (Brouwers et al.,2006).  
 
Behavioural factors 
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Parental age 
Women become pregnant at different ages but, overall, maternal and paternal age at time of 
conception did not seem to increase the risk of having a son with hypospadias (Akre et al.,1999; 
Weidner et al.,1999; Källén,2002; Hussain et al.,2002; Aschim et al.,2004a; Sørensen et al.,2005a; 
Morera et al.,2006; Meyer et al.,2006; Brouwers et al.,2007; Akre et al.,2008; Materna-Kiryluk et 
al.,2009; Sun et al.,2009; Nassar et al.,2009; Ghirri et al.,2009; Lund et al.,2009; Brouwers et 
al.,2010). However, some studies reported a higher maternal age (Fisch et al.,2001; Hussain et 
al.,2002; Carmichael et al.,2003; Reefhuis and Honein,2004; Porter et al.,2005; Carmichael et 
al.,2007; Fisch et al.,2009; Akin et al.,2011) or lower or higher paternal age (McIntosh et al.,1995; 
Materna-Kiryluk et al.,2009) to increase hypospadias risk.  
 
Maternal diet 
In 2000, North and Golding reported a five times increased risk of a hypospadias-affected son for 
women with a vegetarian diet (North and Golding,2000), a finding that was confirmed in one study 
(Akre et al.,2008) but not in others (Brouwers et al.,2007; Ormond et al.,2009; Brouwers et al.,2010). 
However, all of these results were based on case-control studies with relatively few exposed cases and 
controls (<15) except for a study in England reporting no association in more than 75 cases and 
controls who were vegetarian (Ormond et al.,2009). The suggestion that an increased risk might be 
related to intake of phytoestrogens was refuted by a small study involving phytoestrogen-specific 
questionnaires that did not find an association (Pierik et al.,2004). Another dietary factor found to be 
associated with hypospadias in two small studies is the frequent consumption of fish, possibly 
associated with the bioaccumulation of contaminants in fish (Giordano et al.,2008; Giordano et 
al.,2010). However, a larger case-control study found a decreased hypospadias risk for frequent fish 
consumption (Akre et al.,2008).  
 
Other lifestyle factors 
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Alcohol consumption during pregnancy was consistently found not to be associated with hypospadias 
(Hussain et al.,2002; Meyer et al.,2006; Brouwers et al.,2007). For maternal smoking, most studies 
showed no association (Akre et al.,1999; Källén,2002; Hussain et al.,2002; Carmichael et al.,2005b; 
Morera et al.,2006; Meyer et al.,2006; Brouwers et al.,2007; Akre et al.,2008; Brouwers et al.,2010). 
One small study found maternal cocaine use to be associated with hypospadias (Battin et al.,1995). 
 
Occupational factors 
Exposure to pesticides 
Occupational exposures have been a major focus in hypospadias research, especially exposure to 
pesticides, with contradicting results. Paternal exposure to pesticides before pregnancy does not seem 
to be associated with hypospadias (Weidner et al.,1998; Brouwers et al.,2007; Nassar et al.,2009; 
Brouwers et al.,2010), although one small study reported a possibly increased  risk (Giordano et 
al.,2008). In addition, an increased risk was found among farmers who were indicated as exposed to 
pesticides in a register-based study (Kristensen et al.,1997). Most studies showed no association with 
maternal occupational exposure to pesticides (Weidner et al.,1998; Vrijheid et al.,2003; Brouwers et 
al.,2007; Nassar et al.,2009; Brouwers et al.,2010; Morales-Suarez-Varela et al.,2011) but being 
involved in agricultural activities (Sun et al.,2009) or using insect repellents (Dugas et al.,2010) 
seemed to increase hypospadias risk in two studies. Maternal serum levels of 
dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethane (DDE) during pregnancy 
were not associated with hypospadias (Longnecker et al.,2002; Bhatia et al.,2005) but maternal serum 
hexachlorobenzene (HCB) concentrations approximately one year after birth were more often above 
the median of all subjects among hypospadias cases than among controls (Giordano et al.,2010).  
 
Other occupational exposures 
Boys conceived to mothers employed in the leather industry (García and Fletcher,1998) and post-war 
to mothers who served in the Gulf war (Araneta et al.,2003) seemed to have a higher prevalence of 
hypospadias. Most other maternal occupational exposures were not associated with hypospadias, 
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although results for EDCs, heavy metals and phthalates vary, while exposure to hairspray increased 
the risk in one study (Vrijheid et al.,2003; Brouwers et al.,2007; Ormond et al.,2009; Nassar et 
al.,2009; Brouwers et al.,2010; Giordano et al.,2010; Morales-Suarez-Varela et al.,2011). For fathers, 
being a vehicle mechanic or manufacturer (Schnitzer et al.,1995; Irgens et al.,2000), police officer or 
fire fighter (Schnitzer et al.,1995), and occupational exposure to dusts from grinding metals (Brouwers 
et al.,2010) seemed to increase the risk of having a son with hypospadias. Results on heavy metals 
vary (Nassar et al.,2009; Morales-Suarez-Varela et al.,2011) but most other paternal occupational 
exposures were not associated with hypospadias (Brouwers et al.,2007; Nassar et al.,2009; Brouwers 
et al.,2010; Morales-Suarez-Varela et al.,2011).  
 
Living environment 
Results on living in rural or (sub)urban areas are contradictory (Sun et al.,2009; Nassar et al.,2009), 
whereas living close to a landfill site seemed to be associated with an increased hypospadias risk 
(Dolk et al.,1998). Maternal serum levels of polychlorinated biphenyls (PCBs) were elevated during 
pregnancies affected by hypospadias in two small studies but these results were not statistically 
significant (Carmichael et al.,2010; Giordano et al.,2010). Another study found marginally increased 
PCB levels in serum samples of women pregnant with a hypospadias-affected son, but the study 
samples were collected in the 1960s, when PCB exposure was substantially higher than nowadays 
(McGlynn et al.,2009). Maternal exposure to water disinfection by-products was also suggested to 
increase hypospadias risk but most studies provided little evidence for this association (Källén and 
Robert,2000; Luben et al.,2008; Iszatt et al.,2011). 
 
In one study, the prevalence of hypospadias seemed to be higher in areas of intensive pesticide use or 
in agricultural areas (Morera et al.,2006). Another study showed an increased risk of hypospadias for 
living in an area where diclofopmethyl was applied but a decreased risk for alachlor and permethrin, 
or for pesticide application in aggregate (Meyer et al.,2006).  
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In some older studies, a seasonal trend for hypospadias was identified (Wehrung and Hay,1970; 
Roberts and Lloyd,1973; Avellan,1977), which was attributed to factors such as hours of daylight, 
climate or temperature, whereas more recent studies did not find seasonal variation (Skriver et 
al.,2004; Morera et al.,2006; Jin et al.,2010).  
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CONCLUSION 
Most hypospadias cases have an unknown aetiology, which is likely to be a mix of monogenic and 
multifactorial forms, implicating both genes and environmental factors. Several mutations have been 
found that might cause hypospadias but most investigators are convinced that single mutations are not 
likely to be the cause for the majority of isolated hypospadias cases. Neverteheless, studies screening 
patients with hypospadias for single-gene defects found mutations in the genes WT1, SF1, BMP4, 
BMP7, HOXA4, HOXB6, FGF8, FGFR2, AR, HSD3B2, SRD5A2, ATF3, MAMLD1, MID1 and BNC2. 
Association studies found polymorphisms in FGF8, FGFR2, AR, HSD17B3, SRD5A2, ESR1, ESR2, 
ATF3, MAMLD1, DGKK, MID1, CYP1A1, GSTM1 and GSTT1 to be risk factors for hypospadias. In 
addition, gene expression studies indentified CTGF, CYR61 and EGF as candidate genes. 
 
Additional evidence for the involvement of genes can be derived from syndromes commonly 
associated with hypospadias, which were not reviewed in this article. For example, additional evidence 
for the involvement of WT1 comes from the fact that WT1 mutations cause syndromes such as Denys-
Drash and Frasier syndromes, characterized by progressive nephropathy, intersex and predisposition to 
develop genitourinary tumours (Morrison et al.,2008). Male cases having hypospadias were reported 
for both syndromes (Sherbotie et al.,2000; Melo et al.,2002; Kaltenis et al.,2004). Syndromes which 
are commonly associated with hypospadias can also help in the indentification of new candidate 
genes. One example is hand-foot-genital syndrome, which is caused by mutations in HOXA13 
(Mortlock and Innis,1997; Goodman and Scambler,2001). Hoxa13 mutant mice also exhibited 
hypospadias (Morgan et al.,2003) and expansion of a polyalanine tract in HOXD13 found in 
synpolydactyly families also seems to be associated with hypospadias (Goodman et al.,1997; Tüzel et 
al.,2007). Mutations in zinc finger E-box binding homeobox 2 (ZEB2) cause Mowat-Wilson 
syndrome, which is associated with hypospadias in more than 50% of affected males (Mowat et 
al.,2003; Zweier et al.,2005; Adam et al.,2006; Garavelli and Mainardi,2007; Garavelli et al.,2009).  
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Additional candidate genes for hypospadias aetiology include genes for which mutations were 
described in case reports, such as CYP11A1 (Rubtsov et al.,2009), CYP17A1 (Sherbet et al.,2003) and 
HSD17B3 (Lee et al.,2007). 
 
Animal studies also provide some additional candidate genes, such as the genes encoding the cell-
surface molecules ephrins and their receptors, EPH receptor B2 (EphB2) and Ephrin-B2 (Efnb2) 
(Lorenzo et al.,2003; Dravis et al.,2004). EFNB2 has been suggested as the gene underlying genital 
malformations in patients with a 13q33-34 deletion (Garcia et al.,2006; Walczak-Sztulpa et al.,2008; 
Andresen et al.,2010).  
 
In conclusion, many candidate genes have been suggested for hypospadias. Although some 
associations with hypospadias were found, none of these associations were replicated consistently, 
with the possible exception of DGKK. Therefore, we suggest that a genome-wide association study 
using individual genotyping of a large group of cases and controls is the way forward to generate more 
knowledge about the genetic factors underlying isolated hypospadias. In addition, the novel exome or 
even whole-genome sequencing techniques generate new opportunities. Currently, the high costs make 
these techniques only suitable for identification of causes of monogenic forms of hypospadias but with 
falling prices, the techniques may also be applied to large cohorts of patients with isolated hypospadias 
in the future.  
 
As for environmental factors, development of the male external genitalia is dependent on the balance 
between androgens and estrogens. The fact that maternal exposure to synthetic estrogens can induce 
hypospadias in murine models (Kim et al.,2004) and that antiandrogens acting as inhibitors of steroid 
hormone synthesis or AR antagonists can induce male reproductive abnormalities in animal models 
(Gray et al.,2001) suggests that EDCs have the potential to induce hypospadias. However, because of 
considerable species differences and markedly different estrogen levels in humans compared to rodent 
pregnancy, it is debatable whether EDCs also induce hypospadias in humans. Phthalates inhibit 
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steroidogenesis in the foetal rat testis but this does not occur in vitro with human foetal Leydig cells 
(van Gelder et al.,2010). The question remains as to whether exposure levels in humans are high 
enough to exert an effect on the occurrence of hypospadias. Given that even exposures to high levels 
of exogenous hormones, such as in case of hormonal stimulation used to induce pregnancy and use of 
oral contraceptives while pregnant, do not show consistent associations with hypospadias, we suggest 
that exogenous hormones and EDCs may not be as important in the aetiology of hypospadias as has 
previously been assumed.  
 
The consistent association of hypospadias with low birthweight, maternal hypertension and 
preeclampsia suggests that placental insufficiency may be a major risk factor for hypospadias, possibly 
through inadequate provision of hCG to the foetus. A role for endogenous hormones is suggested by 
free estradiol levels linked to high maternal BMI, primiparity and multiple pregnancies that appear to 
contribute to susceptibility to hypospadias.  
 
In addition, maternal intrauterine DES exposure, use of anti-epileptic drugs, pre-existing diabetes, 
prolonged TTP and pregnancies resulting from ICSI have been associated with hypospadias in most 
studies. Other potential environmental risk factors were not, or not consistently, associated with 
hypospadias or studied too infrequently to draw conclusions.   
 
In our opinion, the lack of replication of results for both genetic and environmental factors associated 
with hypospadias may be related to subtle isolated effects of factors that may have larger influences in 
combination with other factors (e.g. gene-gene or gene-environment interactions). While a different 
genetic background of a population may affect its vulnerability to an environmental exposure, 
different environmental exposures may influence the effect of a genotype. Therefore, we think that the 
challenges for future research in disentangling the pathogenesis of hypospadias mainly lie in studies 
focussing on gene-gene or gene-environment interactions. 
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TABLES  
 
 
TABLE I. Mutations found in studies screening candidate genes in groups of patients with hypospadias 
  
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
 
Indifferent stage of development 
 
      
WT1 11p13   35     - different ethnicities -    (Nordenskjöld et al.,1999) 
  90 276 Chinese N130N 
 
A131T 
S159S 
• penoscrotal, micopenis 
• penile 
• penile 
• glandular, also has BMP7 mutation 
hetero 
hetero 
hetero 
hetero 
 
 
 
 
(Wang et al.,2004) 
WTAP 6q25-
q27 
  37   20 controls are Caucasian, 
ethnicity cases ? 
-    (Utsch et al.,2003) 
SF1 11q13   60a 100 ? Q107X 
 
c.103-3C>Ab 
 
E11X 
• penoscrotal, bilateral cryptorchidism 
 
• scrotal, micropenis, bilateral 
 cryptorchidism 
• penoscrotal, micropenis, bilateral 
 cryptorchidism 
hetero 
 
hetero 
 
hetero 
•  showed that variant impairs 
 transcriptional activity 
 
 
• showed that variant impairs 
 transcriptional activity 
(Köhler et al.,2009)  
 
Early patterning stage of development 
 
     
BMP4 14q22-
q23 
  90 190 Chinese H207D  
R223H 
H251Y 
• penoscrotal, micropenis 
• penoscrotal 
• penile, micropenis 
hetero 
hetero 
hetero 
 (Chen et al.,2007) 
BMP7 20q13   60c   96 different ethnicities -    (Beleza-Meireles et 
al.,2007c) 
  90 190 Chinese R303C  
Q199Q 
c.1465T>Ad 
c.1567A>Gd 
• glandular, also has WT1 mutation 
• penile 
• penoscrotal, micropenis 
• penile 
hetero 
hetero 
hetero 
hetero 
 (Chen et al.,2007) 
HOXA4 7p15.2   90 190 Chinese G129C 
S290C 
 
• penoscrotal, micropenis 
• penile, bifid scrotum, cryptorchidism 
• penile, micropenis, also has SRD5A2 
 mutation 
hetero 
hetero 
hetero 
 (Chen et al.,2007) 
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TABLE I. (continued) Mutations found in studies screening candidate genes in groups of patients with hypospadias 
 
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
HOXB6 17q21.3   90 190 Chinese P42T  
 
 
C123R 
• scrotal, micropenis, bifid scrotum, 
 cryptorchidism, also has SRD5A2 
 and MID1 mutations 
• penile 
hetero 
 
 
hetero 
• mother heterozygous (Chen et al.,2007) 
HOXA13 7p15.2   37   20 controls are Caucasian, 
ethnicity cases ? 
-    (Utsch et al.,2003) 
FGF8 10q24   60 c   96 different ethnicities c.590C>Ge • ? homo • Swedish patient (Beleza-Meireles et 
al.,2007c) 
FGF10 5p13-
p12 
  60 c   96 different ethnicities -    (Beleza-Meireles et 
al.,2007c) 
FGFR2 10q26   60 c   96 different ethnicities M186Tf 
c.2454C>Te 
• midpenile 
• ? 
hetero 
hetero 
• Swedish patient 
• Swedish patient 
(Beleza-Meireles et 
al.,2007c) 
 
Masculinisation stage of development 
 
     
SRY Y   90 276 Chinese -    (Wang et al.,2004) 
SOX9 17q23   90 276 Chinese -    (Wang et al.,2004) 
AR Xq12   21   90 ? V870A • penoscrotal, bilateral cryptorchidism hemi  (Hiort et al.,1994) 
    9g     - ? G566V • perineal hemi • family history suggested 
 familial component  
(Alléra et al.,1995) 
  40h     - ? P546S • distal penile shaft hemi  (Sutherland et al.,1996) 
  35     - different ethnicities F725V 
 
 
 
 
S597T 
• hypospadias and cryptorchidism, 
 clinically diagnosed with PAIS based 
 on sparse body hair, gynaecomastia 
 and heredity for intersex malfor-
 mations 
• severe hypospadias, cryptorchidism, 
 bifid scrotum 
hemi 
 
 
 
 
hemi 
 
 
(Nordenskjöld et al.,1999) 
  21 100 Japanese -    (Muroya et al.,2001) 
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TABLE I. (continued) Mutations found in studies screening candidate genes in groups of patients with hypospadias 
 
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
AR Xq12   90 276 Chinese I664T 
R840H 
 
 
 
 
 
I842T   
R855H   
 
 
 
 
 
L859L 
• glandular, gynecomastia 
• perineal, micropenis, bifid scrotum 
 
 
 
 
 
• scrotal, micropenis, bifid scrotum 
• perineal, micropenis, bifid scrotum 
 
 
 
 
 
• penile 
hemi 
hemi 
 
 
 
 
 
hemi 
hemi 
 
 
 
 
 
hemi 
 
• mother heterozygous, variant 
 previously described in ambi-
 guous genitalia patient and 
 shown by others to reduce 
 androgen-binding affinity and 
 transcriptional activity 
• mother heterozygous 
• mother heterozygous, uncle has 
 same mutation and phenotype, 
 variant previously described in 
 2 brothers with perineal hypo-
 spadias, bilateral cryptor-
 chidism and micropenis 
(Wang et al.,2004) 
  37i     - different ethnicities Q798E • scrotal hemi • variant previously described in 
 various genital defects and 
 shown by others to affect AR 
 transactivation function 
(Thai et al.,2005) 
  92 190 Iranian -    (Radpour et al.,2007) 
FKBP4 12p13.33   91     - different ethnicities -    (Beleza-Meireles et 
al.,2007a) 
HSD3B2 1p13.1   90g 101 ? S213T 
 
 
S284R   
 
A238A   
T259T  
 
• scrotal, bilateral cryptorcidism 
 
 
• midshaft 
 
• midshaft 
• proximal penile, micropenis and 
 Wilms’ tumour (no WT1 mutation) 
hetero 
 
 
hetero 
 
hetero 
hetero 
 
• mother and brother hetero-
 zygous, showed that variant 
 reduces enzyme activity 
• de novo, showed that variant 
 reduces enzyme activity 
 
• de novo  
 
(Codner et al.,2004) 
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TABLE I. (continued) Mutations found in studies screening candidate genes in groups of patients with hypospadias 
 
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
HSD3B2 1p13.1   90g 101 ? T320T   • subcoronal hetero • father heterozygous, has bifid 
 preputium and a wide meatus 
(Codner et al.,2004) 
HSD17B3 9q22   19j     - different ethnicities -    (Thai et al.,2005) 
SRD5A2 2p23   35     - different ethnicities -    (Nordenskjöld et al.,1999) 
  81k 100 different ethnicities L113V  
H231R 
• penoscrotal 
• scrotal 
hetero 
hetero 
 
• variant previously described in 
 5α-reductase deficiency 
(Silver and Russell,1999) 
  90 276 Chinese R227Q 
 
 
 
 
 
 
R246Q 
 
 
 
 
 
Q6X     
  
 
 
 
 
L224H 
 
 
656delT 
• penile, bifid scrotum, also has HOXA4
 mutation 
• scrotal, micropenis, bifid scrotum 
• glandular 
 
 
 
• scrotal, bifid scrotum, cryptorchidism 
 
 
 
 
 
• scrotal, micropenis, bifid scrotum, 
 cryptorchidism 
• scrotal, micropenis, bifid scrotum, 
 cryptorchidism, also has G203S 
 variant (also found in controls) and 
 HOXB6 and MID1 mutation 
• scrotal, micropenis, bifid scrotum, 
 also has G203S variant 
 
• perineal, micropenis, bifid scrotum, 
 cryptorchidism 
homo 
 
homo 
hetero 
 
 
 
homo 
 
 
 
 
 
homo 
 
hetero 
 
 
 
hetero 
 
 
hetero 
• variant previously described in
 patient with scrotal hypospa-
 dias, bifid scrotum and micro-
 penis and shown by others to 
 inhibit NADPH binding, 
 reduce testosterone binding, 
 and reduce enzyme half-life  
• variant previously described in 
 2 patients with perineoscrotal 
 hypospadias, micropenis and 
 cryptorchidism and shown by 
 others to reduce enzyme 
 activity 
 
 
• father heterozygous 
 
 
 
• father heterozygous, 2 brothers 
 of patient have same geno-
 type and phenotype as patient 
(Wang et al.,2004) 
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TABLE I. (continued) Mutations found in studies screening candidate genes in groups of patients with hypospadias 
 
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
SRD5A2 2p23   37i     - different ethnicities G196S 
 
 
 
• scrotal 
 
 
 
hetero 
 
 
 
• mother heterozygous, variant 
 previously described in homo-
 zygous form in 8 patients with 
 scrotal hypospadias and micro-
 penis and shown by ohers to 
 partly disrupt NADPH binding 
(Thai et al.,2005) 
SRD5A1 5p15   10l   49 ? -    (Tria et al.,2004) 
 
Other genes 
 
     
ESR1 6q25.1   60   94 different ethnicities -    (Beleza-Meireles et 
al.,2006) 
ESR2 14q23.2   60   94 different ethnicities -    (Beleza-Meireles et 
al.,2006) 
ATF3 1q32.3   93   96 different ethnicities A90G 
c.817C>Td 
 
• moderate 
• moderate/severe 
• moderate/severe 
? 
? 
? 
• Swedish patient 
• Middle Eastern  patient 
• Swedish patient 
(Beleza-Meireles et 
al.,2008) 
  41   30 ? L23M • anterior hetero  (Kalfa et al.,2008a) 
MAMLD1 Xq28 166 460 different ethnicities E124X 
 
 
 
Q197X 
R653X 
• penoscrotal, cryptorchidism, bifid 
 scrotum 
 
 
• penoscrotal, micropenis, bifid scrotum 
• penoscrotal, micropenis, cryptor-
 chidism, bifid scrotum 
hemi 
 
 
 
hemi 
hemi 
• Japanese patient, mother 
 heterozygous, maternal half-
 brother has same mutation 
 and similar phenotype 
• Japanese patient 
• Japanese patient, mother 
 heterozygous 
(Fukami et al.,2006) 
  41   30 different ethnicities V432Am 
L121X 
 
p.531ins3Qn 
• proximal penile 
• proximal penile, cryptorchidism 
• penoscrotal 
• coronal 
hemi 
hemi 
hemi 
hemi 
 
 
• de novo 
 
(Kalfa et al.,2008b) 
  99o   95 ? Q529K 
D686D 
• severe, bilateral cryptorchidism 
• ? 
hemi 
hemi 
 
 
(Chen et al.,2010) 
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TABLE I. (continued) Mutations found in studies screening candidate genes in groups of patients with hypospadias 
 
Gene Locus N 
ca-
ses 
N 
con-
trols 
Ethnicity Mutation 
 
 Phenotype Hetero-
zygosity 
 Remarks Reference 
MID1 Xp22 114   95 ? E238X 
 
 
 
K560R 
• penoscrotal, hypertelorism 
 
 
 
• penoscrotal, hypertelorism 
hemi 
 
 
 
hemi 
• mother heterozygous, brother 
 has same mutation and 
 phenotype, variant previously 
 describeded in Opitz syndrome  
(Zhang et al.,2011) 
INSL3 19p13.2-
p12 
  94 270 Moroccan -    (El Houate et al.,2007) 
BNC2 9p22.2   48p   23 different ethnicities A923V 
 
L414V 
P306A 
P579L 
E240G, 
 R283G, &  
 Q152R 
• distal 
• distal 
• distal 
• distal 
• distal 
• distal 
 
 
hetero 
hetero 
hetero 
hetero 
hetero 
hetero 
hetero 
hetero 
• Caucasian patient 
• African-American patient 
• Caucasian patient 
• Caucasian patient 
• Caucasian patient 
• Caucasian patient 
(Bhoj et al.,2011) 
 
All studies included in this table screened patients with hypospadias for mutations in specific genes. Most studies checked whether mutations were present in 
healthy controls. The table includes only exonic (including 3’-UTR and splice acceptor sites) mutations that were not found in healthy controls, were not 
previously reported polymorphisms, and were not described as a polymorphism by the authors of the article. Results from functional analyses, either 
performed by the study reporting the mutation or performed by earlier studies and referred to by the study reporting the mutation, are included in the table. 
Most studies included patients with different degrees of hypospadias or information about phenotype was not reported. Most studies excluded syndromal 
patients, but did not exclude patients with cryptorchidism, micropenis, bifid scrotum, or other associated anomalies, or information about associated anomalies 
was not reported. Most studies did not exclude patients with affected relatives or information about affected relatives was not reported. Family members 
carrying the same mutation were unaffected, unless indicated differently.  
 
N, number; hetero, heterozygous; homo, homozygous; hemi, hemizygous; PAIS, partial androgen insensitivity syndrome; aonly DSD (disorders of sex 
development) patients with severe penile to penoscrotal hypospadias included; bsplice acceptor site; conly patients with at least one affected relative included; 
d3’-UTR; esynonymous variant, not mentioned in which amino acid; fvariant is known as rs755793, but with allele frequency of 0% in Caucasians; gonly 
patients with severe hypospadias included; honly patients without other genitourinary abnormalities included; ionly patients with severe hypospadias or a 
familial form included; jonly patients from families contributing most to a linkage peak in the vicinity of HSD17B3 included; kpatients with cryptorchidism, 
intersex condition, or endocrine abnormalities excluded; lonly patients with elevated testosterone/DHT ratios without mutations in AR or SRD5A2 included; 
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mvariant was later found in 2 more patients and in 2 controls (Chen et al.,2010); nvariant was later found in 3 more patients and in 1 control (Chen et al.,2010); 
oonly sporadic patients included; ponly patients with distal hypospadias included. 
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TABLE II. Genetic association results for hypospadias 
 
Gene Locus SNP N 
cases 
N 
controls 
Controls Ethnicity Genotypes / alleles asso-
ciated with increased risk  
(P < 0.05) 
Reference 
 
Early patterning stage of development 
 
     
FGF8 10q24 rs3218238 or    
    rs3218233a 
  60b   96 healthy voluntary blood donors different ethnicities A allelec (Beleza-Meireles et 
al.,2007c)d 
FGFR2 10q26 c.382+52→G 
c.550+27T>C 
c.727+180T>G 
  60b   96 healthy voluntary blood donors different ethnicities G allele of c.382+52→Ge
C / T allele of c.550+27T>Ce 
G allele of c.727+180T>Gc 
(Beleza-Meireles et 
al.,2007c)d 
 
Masculinisation stage of development 
 
      
AR 
  
Xq12 CAG repeat   78f  425 anonymous females ? longer repeat (Lim et al.,2000) 
  21  100 boys with short stature and normal external 
genitalia and fertile males 
Japanese no association (Muroya et al.,2001) 
  51  210 males from military service, no history of 
hypospadias or cryptorchidism 
cases are Caucasian,  
controls have Swedish  
mothers 
no association (Aschim et al.,2004b) 
  92  190 fertile males Iranian no association (Radpour et al.,2007) 
GGN repeat   51  210 males from military service, no history of 
hypospadias or cryptorchidism 
cases are Caucasian,  
controls have Swedish  
mothers 
longer repeatg (Aschim et al.,2004b) 
  92  190 fertile males Iranian longer repeatg (Radpour et al.,2007) 
FKBP4 12p13.33 rs1062478 
rs3021522 
333  380 voluntary blood donors different ethnicities no association (Beleza-Meireles et 
al.,2007a) 
HSD17B3 9q22 rs4743709 
rs2066476 
rs2066474  
rs2066480 
rs2066479 
  89h  291 male newborns without malformations Japanese A allele of rs2066479 
AA genotype of rs2066479 
(Sata et al.,2010) 
SRD5A2 2p23 rs9282858   81i 100+ normal controls different ethnicities T allele (Silver and Russell,1999)j 
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TABLE II. (continued) Genetic association results for hypospadias 
Gene Locus SNP N 
cases 
N 
controls 
Controls Ethnicity Genotypes / alleles asso-
ciated with increased risk  
(P < 0.05) 
Reference 
SRD5A2 2p23 rs523349   90    87 normal males Chinese G allele 
CG and GG genotypes 
(Wang et al.,2004) 
158    96 unaffected persons cases have different 
ethnicities, controls 
are Caucasian 
G allele  
CG and GG genotypes 
(Thai et al.,2005) 
  89h  281 male newborns without malformations Japanese CG genotypek (Sata et al.,2010) 
620  596 unaffected males Caucasian no association (van der Zanden et 
al.,2010b)l 
 
Other genes 
 
      
ESR1 6q25.1 rs6932902m   43  135 boys with short stature and normal external 
genitalia and fertile males 
Japanese A allele 
AA genotype 
(Watanabe et al.,2007) 
620  596 unaffected males Caucasian A allele (van der Zanden et 
al.,2010b)l 
TA repeat 
rs1801132 
  90    94 voluntary blood donors different ethnicities no association (Beleza-Meireles et 
al.,2006) 
rs2234693 
rs9340799 
  59h  286 boys without malformations Japanese A allele of rs9340799 (Ban et al.,2008) 
ESR2 14q23.2 CA repeat   90    94 voluntary blood donors different ethnicities longer repeat (Beleza-Meireles et 
al.,2006) 
354  380 healthy voluntary blood donors different ethnicities longer repeat (Beleza-Meireles et 
al.,2007b) 
rs1887994 
rs1256040 
rs1256062 
rs10483774 
rs1271572 
354  380 healthy voluntary blood donors different ethnicities G allele of rs10483774 
AG genotype of rs10483774 
(Beleza-Meireles et 
al.,2007b) 
rs944050   90    94 voluntary blood donors different ethnicities AG genotypen (Beleza-Meireles et 
al.,2006) 
  59h  286 boys without malformations Japanese AG genotypeo (Ban et al.,2008) 
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TABLE II. (continued) Genetic association results for hypospadias 
Gene Locus SNP N 
cases 
N 
controls 
Controls Ethnicity Genotypes / alleles associa-
ted with increased risk 
(P < 0.05) 
Reference 
ESR2 14q23.2 rs2987983 354  380 healthy voluntary blood donors different ethnicities G allele  
GG genotype 
(Beleza-Meireles et 
al.,2007b) 
620  596 unaffected males Caucasian AG genotypeo (van der Zanden et 
al.,2010b)l 
rs1256049 
rs4986938 
  51  186 control males from military service without 
genital anomalies and with sperm 
concentrations  >5×106 spermatozoa/ml 
cases are Caucasian,  
controls have Swedish  
parents 
no association (Aschim et al.,2005) 
ATF3 1q32.3 rs11119982 330  380 healthy voluntary blood donors different ethnicities C allele 
CC genotype 
(Beleza-Meireles et 
al.,2008) 
620  596 unaffected males Caucasian T allele  
TT and CT genotypes 
(van der Zanden et 
al.,2010b)l 
rs2137424 
rs3125289 
rs1877474 
rs10735510 
rs9429889 
rs12070345 
rs10475 
330  380 healthy voluntary blood donors different ethnicities T allele of rs3125289 
TT genotype of rs3125289  
T allele of rs1877474 
TT genotype of rs1877474 
strongest association for com- 
 bination of risk alleles: 
 rs3125289 (T), rs1877474 
 (T) and rs11119982 (C)  
(Beleza-Meireles et 
al.,2008) 
MAMLD1 Xq28 rs61740566 370  380 healthy voluntary blood donors ? no association (Chen et al.,2010) 
rs41313406 
rs2073043 
370  418 male healthy voluntary blood donors ? T allele of rs41313406  
G allele of rs2073043 
(Chen et al.,2010) 
DGKK Xp11.22 rs1934179 
rs7063116 
436p 
133p 
266p 
449 
133 
402 
healthy control males 
mothersq 
male healthy voluntary blood donors 
Caucasian A allele of rs1934179 
A allele of rs7063116 
(van der Zanden et 
al.,2010a)r 
MID1 Xp22 rs16986145 366 405 male controls ? A alleles (Zhang et al.,2011) 
CYP1A1 
GSTM1 
GSTT1 
15q24.1 
1p13.3 
22q11.23 
? 
gene deletion 
gene deletion 
  31t    64 mothers of boys without any malformation Japanese heterozygous CYP1A1 
 genotypeo 
(Kurahashi et al.,2005) 
CYP1A1 
GSTM1 
GSTT1 
15q24.1 
1p13.3 
22q11.23 
? 
gene deletion 
gene deletion 
  80  120 age-matched boys ? concomitant deletion of 
 GSTM1 and GSTT1 
(Yadav et al.,2011) 
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Most studies were association studies with a case-control design. Most studies included patients with different degrees of hypospadias. Most studies excluded 
syndromal patients, but did not exclude patients with cryptorchidism, micropenis, bifid scrotum, or other associated anomalies or information about associated 
anomalies was not reported. Most studies did not exclude patients with affected relatives or information about affected relatives was not reported. Deviations 
from these statements are included in the specified footnotes. 
 
N, number; athe SNP reported in the text was different from the SNP reported in the table; ball patients have at least one affected relative; cthis SNP was found 
in heterozygous form in 3 patients, while it was not found in controls; dthis was not an association study, but a study screening FGF8 and FGFR2 for 
mutations; ethese SNPs were found in heterozygous form in 1 patient, while they were not found in controls. For c.550+27T>C it is not clear whether T or C is 
the risk allele because the SNP reported in the text was different from the SNP reported in the table (c.550+27T>C and c.550+27C>T); fundermasculinized 
patients, most of them with perineoscrotal openings and unfused or partially fused scrotum; gonly penile patients have longer repeats; hpatients with affected 
family members excluded; ipatients with cryptorchidism, intersex condition, or endocrine abnormalities excluded; jthis was not an association study, but a 
study screening SRD5A2 for mutations. This SNP was found in homozygous form in 2 patients and in heterozygous form in 3 patients, while it was not found 
in controls. In another study, this SNP was found in 1 out of 37 patients, but as that study did not genotype controls to perform an association analysis, it was 
not included in the table (Thai et al.,2005); konly associated with severe hypospadias; lthis was an association study with a case-parent triad design analyzed 
using the transmission disequilibrium test; mSNP tagged the ‘AGATA’ haplotype of rs926779, rs3020364, rs6932902, rs3020371 and rs3020375; nall six 
patients with this genotype had affected family members, and the SNP was inherited from the affected line twice; oassociated with decreased risk; ponly 
patients with anterior and middle hypospadias included; qthis part of the study was an association study with a case-parent triad design analyzed using the 
transmission disequilibrium test, but as this in an X-chromosomal SNP, only mothers were taken into account; rthis was a genome wide association study with 
a case-control design, suggesting more associations with hypospadias than reported in this table; sfour cases were familial. Two affected relatives carried the 
variant and one did not. Five of the nine cases with the variant had at least one parent born in North Africa, where the A allele is more prevalent; tmothers of 
patients with hypospadias.  
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Table III. Clinical, behavioural, occupational and environmental factors investigated for their 
association with hypospadias in more than one study.  
 
 
 
FACTORS FREQUENTLY INVESTIGATED 
 
 
Factors with consistent results in all studies 
 
Factors consistently associated with hypospadias 
 Low birthweight / being small for gestational age  
 Placental insufficiency 
 Maternal hypertension 
 Preeclampsia 
 Maternal intrauterine diethylstilbestrol exposure 
Factors consistently not associated with hypospadias 
 Gestational diabetes 
 Maternal alcohol consumption  
 
 
Factors with consistent results in most studies 
 
Factors associated with hypospadias in most studies  
 Use of ICSI 
 Prolonged time-to-pregnancy 
 High maternal BMI  
 Primiparity  
 Multiple pregnancy  
 Pre-existing maternal diabetes 
 Maternal medication use:  
  Anti-epileptic drugs 
Factors not associated with hypospadias in most studies 
 Use of oral contraceptives during pregnancy  
 Use of IVF  
 Use of hormonal stimulation to induce pregnancy  
 Maternal medication use:  
  Loratadine 
 Maternal folate supplementation   
 Paternal age  
 Maternal smoking 
 Maternal exposure to water disinfection by-products 
 
Factors showing inconsistent results 
 
 
 Preterm delivery 
 Maternal iron supplementation 
 Maternal age 
 Maternal vegetarian diet 
 Maternal fish consumption 
 Maternal and paternal exposure to pesticides 
 Maternal occupational exposure to: 
  Endocrine disruptors 
  Heavy metals 
  Phthalates 
 Maternal serum levels of polychlorinated biphenyls 
 Seasonal trend 
 
 
FACTORS NOT FREQUENTLY INVESTIGATED 
 
Factors that seem to be associated with hypospadias 
 Paternal subfertility 
 Absence of nausea and vomiting in early pregnancy  
 Bleeding during pregnancy 
 Complications during labour 
 Maternal medication use: 
  Antihypertensive drugs 
 Father being a vehicle mechanic or manufacturer 
 Factors that do not seem to be associated with hypospadias 
 Amount of weight gain during pregnancy 
 Maternal medication use: 
  Corticosteroids  
  Antibiotics 
 Most maternal and paternal occupational exposures  
 
Factors showing inconsistent results 
 
 Early age at menarche  
 Maternal thyroid disease 
 Fever during first trimester of pregnancy  
 Use of progestogens / progestins for threatened abortion 
 Paternal occupational exposure to heavy metals 
 Living in rural or urban areas 
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FIGURES 
 
 
Figure I Hypospadias subgroups 
 
 
 
 
 
 
Figure II Simple schematic drawing of the normal embryology of the human male external 
genitalia, which is disturbed in case of hypospadias development.  
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Figure III Steroidogenesis in the mitochondrium (top) and smooth endoplasmic reticulum 
(bottom) of the foetal Leydig cell 
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